Asa Waldstein, AHPA Cannabis Committee Chair and principal of Supplement Advisory Group, shares best practices for hemp product manufacturing, labeling, and marketing in a three-part Compliance Essentials for Hemp-CBD Companies series for Let's Talk Hemp.
This is the final article in a three-part Compliance Essentials for Hemp-CBD Companies series. I explore commonly overlooked manufacturing, labeling, and marketing essentials that ingestible cannabinoid companies need to be compliant. This third segment focuses on marketing, which is my favorite compliance aspect. Marketing compliance and reading enforcement trends are essential to any regulatory affairs professional, executive, investor, marketing manager, social media supervisor, and sales representative. I love helping companies communicate their marketing messages in a compliant and effective way. This is the core reason I started my consulting company and free Regulatory Education Series.
With a lack of clarity at the federal level, hemp cannabinoid companies should act like they want to be regulated. Although the federal government has an unfavorable position on hemp cannabinoids, it is best to follow dietary supplement marketing regulations, in my opinion. The guardrails of what constitutes a claim in online marketing seem to be evermoving, which is one of the important reasons to follow FDA warning letters. I write a weekly post called Warning Letter Wednesday, where notable enforcement activity and trends are discussed. Join the free LinkedIn group here.
Most warning letters and agency actions occur because of online marketing statements. This article discusses common mistakes and best practices for online marketing.
